🔎 Trials Near Me

Pradžia › Išsėtinė sklerozė › Ohio

Išsėtinė sklerozė klinikiniai tyrimai Ohio

14 tyrimai dėl Išsėtinė sklerozė ieško dalyvių vietose Ohio.

Miestai Ohio

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • University of Cincinnati Medical Center, Cincinnati
  • Riverside Methodist Hospital, Columbus
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-10-01 · NCT06782490

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

  • Local Institution - Site 104, Columbus
Renkami dalyviai2 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-25 · NCT07840326

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Ohio State University Comprehensive Cancer Center, Columbus
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Centerville
  • TG Therapeutics Investigational Trial Site, Centerville
  • TG Therapeutics Investigational Trial Site, Cincinnati
  • ir dar 4
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT06433752

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • University of Cincinnati, Cincinnati
Renkami dalyviai1/2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07477639

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Cleveland Clinic, Cleveland
  • The Ohio State University, Department of Psychiatry, Columbus
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • The Ohio State University- Site Number : 8400009, Columbus
  • The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
Renkami dalyviai3 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-09-15 · NCT07325292

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, Cleveland
  • TG Therapeutics Investigational Trial Site, Columbus
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT06680037

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, Cleveland
Renkami dalyviai1 fazė
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-08-25 · NCT07224373

Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis

  • Louis Stokes Cleveland VA Medical Center, Cleveland
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT07768761

Understanding and Enhancing Human Health and Movement

  • Louis Stokes Cleveland VA Medical Center, Cleveland
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-31 · NCT07738978

Care in Multiple Sclerosis (MS)

  • Cleveland Clinic, Cleveland
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-05 · NCT07011914

Central Vein Sign in Multiple Sclerosis Extension Study

  • Cleveland Clinic Foundation, Cleveland
Renkami dalyviai
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-02-20 · NCT07424027

Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis

  • Cleveland State University, Cleveland
Renkami dalyviai
Amžius nuo 22 iki 75 · Visoms lytims · Atnaujinta 2025-09-24 · NCT05964829

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.